Skip to Content

Hysingla ER FDA Approval History

FDA Approved: Yes (First approved November 20, 2014)
Brand name: Hysingla ER
Generic name: hydrocodone bitartrate
Dosage form: Extended-Release Tablets
Company: Purdue Pharma LP
Treatment for: Chronic Pain

Hysingla ER (hydrocodone) is a single-entity (without acetaminophen) extended-release opioid analgesic for around-the-clock management of moderate to severe chronic pain.

Development Timeline for Hysingla ER

Nov 20, 2014Approval FDA Approves Hysingla ER - Extended-Release Hydrocodone with Abuse-Deterrent Properties

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.